Analysis Tools|
Allele Symbol Allele Name Allele ID |
Ruvbl2M1Btlr mutation 1, Bruce Beutler MGI:5428996 |
||||||||||||
| Summary |
2 genotypes
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
| N |
• mice exhibit a normal response to NP-Ficoll
• B cell development is normal
|
|
• mice exhibit reduced class-switch antibody response in response to recombinant Semliki Forest virus (SFV) encoded antigen compared with control mice
|
|
• T cell deficiency
|
|
• in the spleen
|
|
• in the spleen
|
|
• response in response to recombinant Semliki Forest virus (SFV) encoded antigen
|
|
• 7 days following NP-CGG immunization
• however, levels were normal by day 14
|
|
• 7 days following NP-CGG immunization
• however, levels were normal by day 14
|
|
• mice exhibit reduced class-switch antibody response in response to recombinant Semliki Forest virus (SFV) encoded antigen compared with control mice
|
|
• T cell deficiency
|
|
• in the spleen
|
|
• in the spleen
|
|
• response in response to recombinant Semliki Forest virus (SFV) encoded antigen
|
|
• 7 days following NP-CGG immunization
• however, levels were normal by day 14
|
|
• 7 days following NP-CGG immunization
• however, levels were normal by day 14
|
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 09/30/2025 MGI 6.24 |
|
|
|
||


